You are viewing the site in preview mode

Skip to main content


Fig. 4 | BMC Health Services Research

Fig. 4

From: Clinical trial network for the promotion of clinical research for rare diseases in Japan: muscular dystrophy clinical trial network

Fig. 4

Overall patient cohort of the MDCTN. From 30 out of 31 cooperative sites, 5,589 patients have been reported. This data were calculated based on a rough estimate of the proportion of patients with each disease reported at each site. Abbreviations: MDCTN, Muscular dystrophy clinical trial network; GNE, UDP-N-acetylglucosamine-2-epimerase/N-acetylmannosamine kinase; DM1 and 2, myotonic dystrophy type 1 and type 2; DMD, Duchenne muscular dystrophy; LGMD, Limb-girdle muscular dystrophy; BMD, Becker muscular dystrophy; FCMD, Fukuyama type neuromuscular dystrophy; FSHMD, Facioscapulohumeral muscular dystrophy; CM, Congenital myopathy; CMD, Congenital muscular dystrophy; mito, Mitochondrial myopathy

Back to article page